FIELD: medicine. SUBSTANCE: method involves carrying out continuous perfusion of osmotic active 33% low molecular weight polyvinyl pyrrolidone solution at a rate of 10 ml/h in membrane capsule cavity set into omental bursa using microperistaltic bicanal pump in postoperative period for 7-9 days. EFFECT: prolonged survival period; accelerated treatment course; reduced risk of purulent complications; eliminated early toxicosis phenomena. 3 cl
Authors
Dates
2004-04-10—Published
2002-11-21—Filed